Target intelligence / Profile preview

Cardiac voltage-gated potassium channel (Kv channel)

Target
Kv channel
Molecular classification
Ion channel, Voltage-gated ion channel, Potassium channel
01

Overview

Cardiac voltage-gated potassium channels are a diverse group of transmembrane proteins essential for the electrical activity of the heart (Schmitt et al., 2014). They facilitate the efflux of potassium ions out of cardiomyocytes, primarily during the repolarization phase of the action potential (Nerbonne & Kass, 2005). This group includes various subtypes such as the ultra-rapid (IKur), transient outward (Ito), rapid (IKr), and slow (IKs) delayed rectifier channels, which are encoded by genes such as KCNA5, KCND3, KCNH2, and KCNQ1 (Tamargo et al., 2004). Dysregulation or genetic mutations in these channels are linked to numerous arrhythmias, including atrial fibrillation and long QT syndromes (StatPearls, 2023). Pharmacological modulation of these channels is a cornerstone of antiarrhythmic therapy, though it carries significant risks of pro-arrhythmia due to potential excessive prolongation of the ventricular action potential (Roden, 2016).

Other names
Other cardiac voltage-gated potassium channelsVoltage-gated potassium channels (cardiac)Non-hERG cardiac potassium channelsCardiac Kv channelsVoltage-gated potassium channel subunits
02

Mechanism of action

Blockade of the potassium-conducting pore of voltage-gated channels, which inhibits the efflux of K+ ions during the repolarization phase of the cardiac action potential, thereby prolonging the action potential duration and the effective refractory period (Tamargo et al., 2004).

03

Biological functions

Cardiac repolarizationAction potential duration regulationResting membrane potential maintenanceHeart rate regulationElectrical signaling in cardiomyocytes
04

Disease associations

Cardiac arrhythmiaAtrial fibrillationLong QT syndromeShort QT syndromeBrugada syndromeHeart failure
05

Safety considerations

Pro-arrhythmiaTorsades de PointesDrug-induced long QT syndromeVentricular tachycardiaBradycardiaHeart block
06

Interacting drugs

Amiodarone

8 more in the full profile.

07

Biomarkers

QT intervalQTc intervalPR intervalT-wave morphologyJ-point elevation

Beyond the preview

Go deeper on Cardiac voltage-gated potassium channel (Kv channel).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiac voltage-gated potassium channel (Kv channel).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call